Dopamine and individual differences in social communication
多巴胺与社交沟通的个体差异
基本信息
- 批准号:7538378
- 负责人:
- 金额:$ 25.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-12-10 至 2012-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAnimalsAutoradiographyBehaviorBindingBiologicalBiological ModelsBirdsBrainBrain regionBreedingCannulasCatecholaminesCell NucleusCharacteristicsClinicalCommunicationComplexCopulationCyclic AMPDataDiseaseDopamineDopamine AgonistsDopamine D2 ReceptorDopamine ReceptorEnvironmentEuropeanFeedbackFemaleFundingGoalsHeartHumanImmediate-Early GenesIndividualIndividual DifferencesInterventionLabelLaboratoriesLearningLesionMental disordersMissionModelingMotivationNational Institute of Mental HealthNeuronsNeurotransmittersOxidopaminePharmacological TreatmentPlayProductionProteinsPsychological reinforcementRegulationResearchRewardsRoleSiteSocial BehaviorSocial EnvironmentSocial InteractionSongbirdsStimulusSturnus vulgarisSystemTaxonTestingTyrosine 3-MonooxygenaseVariantVentral Tegmental AreaWestern Blottingautism spectrum disorderbasebehavior testdensitydesigndopamine systemdopamine transporterimmunocytochemistryinsightinterestmalemedial preoptic nucleusneural circuitneurobiological mechanismneurochemistryreceptorreceptor bindingrelating to nervous systemresearch studyresponseskillssocialsocial communicationsocial groupsynthetic enzyme
项目摘要
DESCRIPTION (provided by applicant): Appropriate communication is at the heart of successful, healthy social interactions in humans. Deficits in social communication are a hallmark of several mental disorders, including autism spectrum disorders. Such disorders are characterized by extreme individual variability in the motivation to communicate, and in the ability to engage in socially appropriate communication, yet very little research has been devoted to understanding the neural bases of these issues. Songbirds provide an ideal model system in which to study brain mechanisms regulating appropriate social communication. In our model species we find the brain to differentially regulate communication in a context in which song is directed towards a female (goal-directed) versus song observed in large social groups (group-motivated). In past studies we find that some individuals communicate at high levels and others not at all. Associated with individual differences in communication are differences in activity within brain regions involved in motivation and reward. We have been able to motivate birds to communicate through pharmacological manipulations of dopamine receptors, suggesting dopamine as a candidate neurotransmitter system involved in stimulating communication in individuals that are not highly motivated to communicate. The experiments proposed here test the hypothesis that individual differences in context-appropriate communication are dependent upon dopamine activity within neural systems involved in motivation and reward. To test this hypothesis we will examine the effects of site-specific dopamine lesions (Aim 1) and site-specific dopamine receptor subtype manipulations (Aim 2) on communication within goal- directed and socially-motivated contexts in low- and high-communicating individuals. Neural circuits influenced by these manipulations will be examined after behavioral testing through examinations of markers of neuronal activity and other neurochemical markers. Comparisons will then be made of multiple dopaminergic markers in low- and high-communicators in both contexts to identify differences in the brain associated with natural individual variation in context-appropriate communication (Aim 3). The proposed research will identify manipulations that stimulate context-appropriate social interactions, which can be used in the design of clinical interventions in humans with deficits in the motivation to communicate. The proposed studies span from neurons, to neural circuits, to complex social behavior, integrate what is known about motivation with studies on communication, examine the influence of environment and social context on individuals displaying natural variation in behavior, and will provide treatment ideas for individuals with psychiatric disease. Deficits in social communication are a hallmark of several mental disorders, including autism spectrum disorders. Such disorders are characterized by extreme individual variability in the motivation to communicate, and in the ability to engage in socially appropriate communication. The proposed research will identify manipulations that stimulate context-appropriate social interactions, which can be used in the design of clinical interventions in humans with deficits in the motivation to communicate.
描述(由申请人提供):适当的沟通是人类成功,健康的社会交往的核心。社交障碍是包括自闭症谱系障碍在内的几种精神障碍的标志。这种疾病的特点是在沟通的动机和参与社会适当的沟通能力方面存在极大的个体差异,但很少有研究致力于了解这些问题的神经基础。鸣禽提供了一个理想的模型系统,在其中研究大脑机制调节适当的社会交流。在我们的模型物种中,我们发现大脑在歌曲指向女性(目标导向)与在大型社会群体中观察到的歌曲(群体动机)的背景下差异调节通信。在过去的研究中,我们发现有些人在高水平上交流,而另一些人则根本没有。与交流中的个体差异相关的是大脑中涉及动机和奖励的区域的活动差异。我们已经能够通过多巴胺受体的药理学操作来激励鸟类进行交流,这表明多巴胺作为一种候选神经递质系统参与刺激那些没有高度交流动机的个体的交流。这里提出的实验测试的假设,即在上下文适当的通信的个体差异取决于多巴胺的神经系统内的活动参与动机和奖励。为了验证这一假设,我们将研究特定位点多巴胺病变(目标1)和特定位点多巴胺受体亚型操纵(目标2)对低沟通和高沟通个体目标导向和社会动机背景下沟通的影响。受这些操作影响的神经回路将在行为测试后通过检查神经元活动的标志物和其他神经化学标志物进行检查。然后,在这两种情况下,将在低和高沟通者中进行多个多巴胺能标记物的比较,以确定与背景适当的沟通中的自然个体差异相关的大脑差异(目的3)。拟议的研究将确定刺激上下文适当的社会互动的操作,这可用于设计临床干预措施,在人类的动机沟通赤字。拟议的研究范围从神经元到神经回路,再到复杂的社会行为,将已知的动机与沟通研究相结合,研究环境和社会背景对表现出自然行为变化的个体的影响,并将为患有精神疾病的个体提供治疗思路。社交障碍是包括自闭症谱系障碍在内的几种精神障碍的标志。这种障碍的特点是在沟通的动机和参与社会适当沟通的能力方面存在极大的个体差异。拟议的研究将确定刺激上下文适当的社会互动的操作,这可用于设计临床干预措施,在人类的动机沟通赤字。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lauren V Riters其他文献
Lauren V Riters的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lauren V Riters', 18)}}的其他基金
Mechanisms underlying intrinsically rewarded social behaviors
内在奖励社会行为的潜在机制
- 批准号:
10531277 - 财政年份:2019
- 资助金额:
$ 25.78万 - 项目类别:
Mechanisms underlying intrinsically rewarded social behaviors
内在奖励社会行为的潜在机制
- 批准号:
10311994 - 财政年份:2019
- 资助金额:
$ 25.78万 - 项目类别:
Mechanisms underlying intrinsically rewarded social behaviors
内在奖励社会行为的潜在机制
- 批准号:
10063827 - 财政年份:2019
- 资助金额:
$ 25.78万 - 项目类别:
Opioids and individual differences in social communication
阿片类药物与社交沟通中的个体差异
- 批准号:
8436850 - 财政年份:2007
- 资助金额:
$ 25.78万 - 项目类别:
Dopamine and individual differences in social communication
多巴胺与社交沟通的个体差异
- 批准号:
7989981 - 财政年份:2007
- 资助金额:
$ 25.78万 - 项目类别:
Opioids and individual differences in social communication
阿片类药物与社交沟通中的个体差异
- 批准号:
8589605 - 财政年份:2007
- 资助金额:
$ 25.78万 - 项目类别:
Dopamine and individual differences in social communication
多巴胺与社交沟通的个体差异
- 批准号:
8197538 - 财政年份:2007
- 资助金额:
$ 25.78万 - 项目类别:
Opioids and individual differences in social communication
阿片类药物与社交沟通中的个体差异
- 批准号:
8776974 - 财政年份:2007
- 资助金额:
$ 25.78万 - 项目类别:
Opioids and individual differences in social communication
阿片类药物与社交沟通中的个体差异
- 批准号:
9169940 - 财政年份:2007
- 资助金额:
$ 25.78万 - 项目类别:
Dopamine and individual differences in social communication
多巴胺与社交沟通的个体差异
- 批准号:
7739513 - 财政年份:2007
- 资助金额:
$ 25.78万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 25.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 25.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 25.78万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 25.78万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 25.78万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 25.78万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 25.78万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 25.78万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 25.78万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 25.78万 - 项目类别: